BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswireNov 26 07:50 ET

BriaCell Provides Update to Its Board of Directors

GlobeNewswireNov 25 07:50 ET

Express News | Briacell Provides Update to Its Board of Directors

ReutersNov 25 07:50 ET

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BenzingaNov 21 11:47 ET

Briacell Therapeutics Has Dosed The First Patient In Its Phase 1/2 Study To Evaluate The Safety And Efficacy Of Bria-OTS, Briacell's Personalized Next Generation Immunotherapy

BenzingaNov 21 07:51 ET

BriaCell Announces First Patient Dosed With Bria-OTS in Metastatic Breast Cancer Study

GlobeNewswireNov 21 07:50 ET